文献速递技术与安全介入US

基于低剂量表柔比星给药系统联合聚焦超声的声动力治疗

Sonodynamic Therapy Based on Combined Use of Low Dose Administration of Epirubicin-Incorporating Drug Delivery System and Focused Ultrasound.
PubMed 文献 · Ultrasound Med Biol · 2017-07-10

本文介绍声动力治疗(SDT)以声敏剂药物联合高强度聚焦超声(HIFU)在肿瘤细胞内及周围产生细胞毒性活性氧。研究在结肠癌与胰腺癌小鼠模型中,将低剂量新型表柔比星给药系统NC-6300与低能量HIFU联合,展示了基于给药系统的SDT的有效性与可行性。

要点

  • SDT依靠声敏剂药物与HIFU联合产生细胞毒性活性氧。
  • 蒽环类药物表柔比星与聚焦超声作用后是有效的声敏剂。
  • NC-6300经酸敏感腙键连接表柔比星,既往体内研究显示基本药物安全性和优良的表柔比星浓度特性。

核心结论

  • 在结肠癌与胰腺癌小鼠模型中,低剂量NC-6300联合低能量HIFU的给药系统声动力治疗展示了有效性与可行性,以实现微创癌症治疗。

研究设计与样本

  • 临床前小鼠研究,使用结肠癌与胰腺癌小鼠模型,干预为低剂量NC-6300联合低能量HIFU。
  • NC-6300为经酸敏感腙键连接表柔比星的新型抗癌给药系统,此前已在临床 trials 中受试。

临床应用与阅片要点

  • 作者认为该给药系统声动力治疗可实现微创癌症治疗,其有效性与可行性已在结肠癌与胰腺癌小鼠模型中展示。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Sonodynamic therapy (SDT) is currently considered as one of the promising minimally invasive treatment options for solid cancers. SDT is based on the combined use of a sonosensitizer drug and high-intensity focused ultrasound (HIFU) to produce cytotoxic reactive oxygen species (ROS) in and around neoplastic cells. Anthracycline drugs, including epirubicin (EPI), have been well known as effective sonosensitizers after interaction with focused ultrasound. Recently a new anticancer drug delivery system (DDS), NC-6300, has been developed that comprises EPI through an acid-labile hydrazone bond. In previous in vivo studies, NC-6300 showed basic drug safety and an excellent concentration property of EPI, and recently has been tested in clinical trials. For realizing minimally invasive cancer treatment, the present study demonstrated the effectiveness and feasibility of DDS-based SDT, which combined a small dose of NC-6300 and low energy of HIFU in mouse models of colon cancer and pancreatic cancer.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Maeda M, Muragaki Y, Okamoto J, et al. Sonodynamic Therapy Based on Combined Use of Low Dose Administration of Epirubicin-Incorporating Drug Delivery System and Focused Ultrasound. Ultrasound Med Biol. 2017. PMID: 28705555. doi:10.1016/j.ultrasmedbio.2017.06.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。